Clinical Trial Update: JSKN033 in Chinese Subjects with Advanced Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of JSKN033 for Chinese patients with advanced malignant tumors; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• JSKN033

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Advanced Malignant Tumors | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING